Table 4.
Incidence of neurological symptoms in CHIKV and WNV confirmed patients.
| Symptom | CHIKV (n) | WNV (n) | OR (95% CI) |
|---|---|---|---|
| Headache | 45% (27) | 42.3% (25) | 1.00 (0.48–2.07) |
| Altered mental status | 19.6% (10) | 28.8% (17) | 0.44 (0.17–1.10) |
| Seizures | 10% (6) | 15.2% (9) | 0.51 (0.16–1.64) |
| Weakness | 6.7% (4) | 5% (3) | 1.36 (0.29–6.35) |
| Encephalitis | 19.6% (10) | 13.5% (8) | 1.3 (0.47–3.57) |
| ADEM | 5% (3) | 11.8% (7) | 0.40 (0.1–1.62) |
| Vertigo | 3.3% (2) | 5% (3) | 0.65 (0.11–4.07) |
| Amy neurological symptoms present | 46.6% (28) | 49.1% (29) | 0.87 (0.42–1.8) |
| Lymphopenia | 53.3% (32) | 20.3% (12) | 4.57 (2.0–10.4) |
Bold font indicates statistical significance.